Dystonia Research Digest

PubMed + Semantic Scholar | Automated Daily

Digest #2

Mar 23, 2026 at 04:00 PM

Download PDF Back to List
7 Papers Found
6 Categories
7 Day Lookback
COMPLETED Status
Botox (2 papers)
PubMed DOI: 10.1055/a-2832-4561
Ondo William G
Semin Neurol | Published: 2026 Mar 17 | PMID: 41844216
Full Details
PubMed DOI: 10.1044/2025_AJSLP-25-00143
Pierce Jenny L, Dwenger Kaitlyn, Sharma Anuja, Jennings Skyler G, Smith Marshall, Barkmeier-Kraemer Julie
Am J Speech Lang Pathol | Published: 2026 Mar 17 | PMID: 41842679
PURPOSE: Adductor-type laryngeal dystonia (AdLD) is a voice disorder with substantial negative effects. The current standard treatment is botulinum toxin (BoNT) injections, with novel treatments on the horizon. The aim of this study was to determine the sensitivity of selected acoustic measures to measure voice quality change from pre-BoNT to the participants' perceived maximum benefit from BoNT. METHOD: Twenty-three participants with AdLD underwent acoustic recordings at pre-BoNT and a subset o...
Full Details
DBS Hardware / Technology (1 papers)
Semantic Scholar DOI: 10.47772/ijriss.2025.906000133
Rifat Hosain
International Journal of Research and Innovation in Social Science | Published: 2025
This study explores how DBS Group, a mid-sized Bangladeshi ready-made garments (RMG) exporter, implements digital transformation technologies—Internet of Things (IoT), blockchain, and Enterprise Resource Planning (ERP)—to enhance supply chain efficiency. Using an exploratory single-case study, secondary data from BGMEA (2024), McKinsey (2021), and Textile Network (2023) were synthesized, with inferred metrics (e.g., 10–15% lead time reduction) benchmarked against RMG standards. Findings show IoT
Full Details
Deep Brain Stimulation (DBS) (1 papers)
PubMed DOI: 10.1002/mds.70275
Grasso Marylou, Moser Pierre-Olivier, Sauvageot Sidonie, Gil Valérie, Chan-Seng Emilie, Sanrey Emily, Coubes Philippe, Poulen Gaëtan
Mov Disord | Published: 2026 Mar 18 | PMID: 41851006
BACKGROUND: Perinatal hypoxic-ischemic encephalopathy (HIE) is a severe condition resulting from impaired oxygen delivery to the developing brain, often leading to both motor deficits and dystonia-dyskinetic syndromes (DDS). In selected cases, deep brain stimulation of the globus pallidus internus (GPi-DBS) may provide a therapeutic option. However, predicting outcomes remains challenging because of clinical heterogeneity and variable responses. OBJECTIVES: This retrospective study aims to ident...
Full Details
Dystonia & Spasticity (1 papers)
PubMed DOI: 10.1007/s00381-026-07219-7
Jain Rishi, Weiss Benjamin E, Snider Elizabeth, Mossner James M, Raskin Jeffrey S
Childs Nerv Syst | Published: 2026 Mar 21 | PMID: 41863662
OBJECTIVE: Intrathecal baclofen (ITB) pumps are essential for managing spasticity and dystonia in children; however, they carry risks of hardware infection, withdrawal syndrome, and emergent failure. Management of these complications remains variable across institutions, and no unified, pediatric-specific workflow exists to date. We sought to develop and implement standard work tools (SWTs) to guide the evaluation and treatment of ITB pump infection and withdrawal in pediatric patients. METHODS:...
Full Details
Dystonia Pain (1 papers)
PubMed DOI: 10.1136/bcr-2025-269687
AlZahrani Abdulrahman, Weber-Adrian Danielle, Ong May C
BMJ Case Rep | Published: 2026 Mar 19 | PMID: 41856690
Complex regional pain syndrome (CRPS) with associated dystonia is a severely debilitating condition often refractory to conventional management. We present a case report of three patients with chronic, treatment-refractory CRPS-related limb dystonia. Patients were treated with multiday intravenous ketamine infusions (target dose 30 mg/hour) every 3-6 months, supplemented with oral ketamine troches. This treatment protocol resulted in the complete resolution of dystonia in two patients and signif...
Full Details
Neuromodulation (1 papers)
PubMed DOI: 10.61409/V08250624
Orlovska-Waast Sonja, Petersen Iben Rix, Sonne David Peick
Ugeskr Laeger | Published: 2026 Mar 02 | PMID: 41848246
A woman with complex psychiatric illness and substance use disorder presented with nausea, vomiting, and episodes of oculogyric crisis. A medication review suggested drug-induced acute dystonia, likely triggered by metoclopramide. Other symptoms were possibly related to cumulative anticholinergic effects. Fluoxetine, a potent CYP2D6 inhibitor, may have increased exposure to metoclopramide and promethazine. This case report demonstrates that pharmacological insight and deprescribing can improve s...
Full Details